Enter your email address below and subscribe to our newsletter

Industry News

Share your love

iuvo BioScience Completes Acquisition of Promedica

iuvo BioScience, a prominent Partner Research Organization (PROTM), announced its successful acquisition of Promedica International, a California Corporation, specializing in ophthalmology-focused clinical Contract Research Organization (CRO) services. The strategic move is poised to create a global leader in delivering comprehensive…

FDA Approves ZEISS’ VISUMAX® 800 for Nearsightedness

The FDA has approved the VISUMAX® 800 equipped with SMILE® pro software from ZEISS. This state-of-the-art femtosecond laser technology is designed for the surgical treatment of nearsightedness, with or without astigmatism. The VISUMAX® 800 enters the U.S. market at a…

Ocuphire Pharma Gets FDA Nod for Dim Light Visual Acuity Trial

In a recent announcement, Ocuphire Pharma disclosed that it has secured approval from the U.S. Food and Drug Administration (FDA) under a special protocol assessment (SPA) for the clinical trial protocol and planned statistical analysis of its LYNX-2 phase 3…

FDA Unveils Updated Guidance for Ophthalmic Drugs

The FDA has released a significant update for the pharmaceutical industry, unveiling a revised draft guidance titled “Quality Considerations for Topical Ophthalmic Drug Products.” This comprehensive guidance addresses crucial quality considerations for various ophthalmic drug products, including gels, ointments, creams,…

Top 10 Medical Devices in Ophthalmology

Medical technology has advanced significantly in recent years, providing numerous benefits to patients and healthcare professionals. In the field of ophthalmology, innovative medical devices have been developed that have revolutionized the way eye conditions are diagnosed and treated. Here are…

Azura Ophthalmics: Phase 2 Results for AZR-MD-001

Azura Ophthalmics reported positive top-line efficacy and safety outcomes from a phase 2 investigation of AZR-MD-001 in individuals experiencing Contact Lens Discomfort (CLD) due to challenges in comfortably wearing lenses and demonstrating signs of meibomian gland dysfunction (MGD). The trial…

The Evolution of Intraocular Lenses

Cataract is the most prevalent ophthalmic disease. Treatment of cataracts has been practiced for centuries using various surgical and nonsurgical procedures. However, avoidance of complications and attainment of high-quality postoperative visual rehabilitation were difficult in the years before the introduction…

How to Deal with the Epithelial Herpetic Keratitis

Trifluridine eye drop, acyclovir (ACV) ointment, ganciclovir gel, and oral ACV are still the main therapeutic agents. Cryopreserved amniotic membrane has been recently used as an adjuvant treatment. Resistance to ACV has become a concerning issue. The animal models of…

Retinal Vasculitis: Causes, Symptoms and Management

Retinal vasculitis is an inflammatory condition affecting the blood vessels of the retina. This inflammation can disrupt the normal blood flow, leading to complications that may compromise visual function. Pathophysiology In retinal vasculitis, inflammatory cells such as neutrophils, macrophages, and…

VSY Unveils Enova Advanced EDoF IOL at EPOMEC 2023

VSY Biotechnology, a leading company in ophthalmic innovations, made a notable presence at the 10th Evolving Practice of Ophthalmology Middle East Conference (EPOMEC 2023) in Dubai. The conference, held from 23-25 November, marked a significant moment for VSY Biotechnology as…

Stay informed and not overwhelmed, subscribe now!